- Home
- BKU vs VCEL Comparison
BKU vs VCEL Comparison
Compare BKU & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKU
- VCEL
- Stock Information
- Founded
- BKU 2009
- VCEL 1989
- Country
- BKU United States
- VCEL United States
- Employees
- BKU N/A
- VCEL N/A
- Industry
- BKU Savings Institutions
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BKU Finance
- VCEL Health Care
- Exchange
- BKU Nasdaq
- VCEL Nasdaq
- Market Cap
- BKU 2.6B
- VCEL 2.1B
- IPO Year
- BKU 2011
- VCEL 1997
- Fundamental
- Price
- BKU $37.26
- VCEL $40.25
- Analyst Decision
- BKU Hold
- VCEL Strong Buy
- Analyst Count
- BKU 11
- VCEL 8
- Target Price
- BKU $40.55
- VCEL $62.00
- AVG Volume (30 Days)
- BKU 815.5K
- VCEL 477.0K
- Earning Date
- BKU 07-23-2025
- VCEL 07-31-2025
- Dividend Yield
- BKU 3.32%
- VCEL N/A
- EPS Growth
- BKU 38.76
- VCEL 521.85
- EPS
- BKU 3.21
- VCEL 0.05
- Revenue
- BKU $972,198,000.00
- VCEL $238,541,000.00
- Revenue This Year
- BKU $13.53
- VCEL $23.03
- Revenue Next Year
- BKU $6.80
- VCEL $24.52
- P/E Ratio
- BKU $11.64
- VCEL $780.58
- Revenue Growth
- BKU 11.13
- VCEL 14.80
- 52 Week Low
- BKU $28.21
- VCEL $37.39
- 52 Week High
- BKU $44.45
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- BKU 61.52
- VCEL 44.06
- Support Level
- BKU $37.25
- VCEL $39.39
- Resistance Level
- BKU $38.13
- VCEL $42.61
- Average True Range (ATR)
- BKU 0.84
- VCEL 1.73
- MACD
- BKU 0.18
- VCEL -0.15
- Stochastic Oscillator
- BKU 78.13
- VCEL 24.16
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.